Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

The glucocorticoid receptor–autophagy axis in inflammation, immunoregulation, and cancer: a bidirectional regulatory network with therapeutic potential

  • Xiuping Wang1,2,3
  • Lingxiang Mao3
  • Yujie Li1
  • Jianjun Wang3
  1. 1Department of Radioimmunology, Affiliated Kunshan Hospital of Jiangsu University
  2. 2Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University
  3. 3Department of Clinical Laboratory, Affiliated Kunshan Hospital of Jiangsu University
Open at sourceDOICite

Abstract

Glucocorticoid receptor (GR) activation and autophagy are central regulators of cellular homeostasis and disease progression. However, the bidirectional interplay between GR signaling and autophagy remains incompletely understood, limiting context-specific insights and the translation of glucocorticoid-based therapies. This review synthesizes current knowledge of their molecular interactions, delineates the continuum from GR activation to the autophagy pathway, and discusses the integrated network governing their crosstalk. Notably, this axis exerts dual functions: it can promote survival or induce cell death, drive or resolve inflammation, and modulate therapeutic sensitivity depending on cellular context, disease state, and ligand characteristics. We review evidence on the GR–autophagy axis in immune cell function, cytokine dynamics, and inflammation control, and focus on its roles in inflammation and cancer pathogenesis, its therapeutic potential, and the challenges of clinical application. By integrating diverse research findings into a coherent framework, this review underscores the microenvironment’s influence on cancer regulatory mechanisms, highlights key therapeutic nodes, and advocates precise modulation of the GR–autophagy relationship as a promising therapeutic strategy.

Related

  1. Inflammation reshapes epidermal and leukocyte differentiation resulting in altered glucocorticoid responsiveness
    E. Faught, T. Schrauwen, A. Wijnants +4
    bioRxivPreprintCC BYFull textImmunologybioRxiv
  2. Cerberus: bidirectional state space blocks improve accuracy and efficiency of regulatory sequence models
    D. R. Kelley, H. Yuan, X. Huang +1
    bioRxivPreprintCC BYFull textGenetics & genomicsbioRxiv
  3. Macrophage immunometabolism in osteoporosis: an emerging regulatory axis linking metabolic–polarization coupling to therapeutic targets
    Lian Weng, Qianli Yuan, Taizhou Mo +3
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  4. Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation
    Hong Yong Peh, Jianmin Chen
    Pharmacology & TherapeuticsPeer-reviewedLicence not statedFull text47 citedGeneral biologyHAL
  5. Editorial: Inflammation and diabetes: unraveling vascular complications and therapeutic innovations
    Federico Biscetti, Luis H Eraso, Maria Margherita Rando +1
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref

Cite

BibTeXRIS
BibTeX
@article{wang2026glucocorticoid,
  title = {{The glucocorticoid receptor–autophagy axis in inflammation, immunoregulation, and cancer: a bidirectional regulatory network with therapeutic potential}},
  author = {Xiuping Wang and Lingxiang Mao and Yujie Li and Jianjun Wang},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1924727},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1924727/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The glucocorticoid receptor–autophagy axis in inflammation, immunoregulation, and cancer: a bidirectional regulatory network with therapeutic potential
AU  - Xiuping Wang
AU  - Lingxiang Mao
AU  - Yujie Li
AU  - Jianjun Wang
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1924727
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1924727/full
AB  - Glucocorticoid receptor (GR) activation and autophagy are central regulators of cellular homeostasis and disease progression. However, the bidirectional interplay between GR signaling and autophagy remains incompletely understood, limiting context-specific insights and the translation of glucocorticoid-based therapies. This review synthesizes current knowledge of their molecular interactions, delineates the continuum from GR activation to the autophagy pathway, and discusses the integrated network governing their crosstalk. Notably, this axis exerts dual functions: it can promote survival or induce cell death, drive or resolve inflammation, and modulate therapeutic sensitivity depending on cellular context, disease state, and ligand characteristics. We review evidence on the GR–autophagy axis in immune cell function, cytokine dynamics, and inflammation control, and focus on its roles in inflammation and cancer pathogenesis, its therapeutic potential, and the challenges of clinical application. By integrating diverse research findings into a coherent framework, this review underscores the microenvironment’s influence on cancer regulatory mechanisms, highlights key therapeutic nodes, and advocates precise modulation of the GR–autophagy relationship as a promising therapeutic strategy.
SN  - 1664-3224
ER  -